Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
48 studies found for:    "Pars planitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Pars planitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
Conditions: Anterior Uveitis;   Intermediate Uveitis
Intervention:
2 Completed Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis;   Noninfectious Uveitis
Intervention: Drug: triamcinolone acetonide (Triesence®)
3 Active, not recruiting Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Conditions: Uveitis;   Anterior Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Scleritis;   Clinically Significant Macular Edema
Intervention: Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
4 Recruiting A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Intervention: Drug: FAI insert
5 Recruiting Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: Sham Injection;   Drug: FAI Insert
6 Active, not recruiting Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
Conditions: Intermediate Uveitis;   Posterior Uveitis;   Pan-uveitis
Intervention: Drug: Tocilizumab
7 Active, not recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
8 Recruiting Intravitreal Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Interventions: Drug: Intravitreal injection 440mcg;   Drug: Intravitreal injection of sirolimus 880mcg
9 Unknown  Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: Sirolimus (rapamycin)
10 Completed Retisert and Cataract Surgery in Patients With Severe Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Intervention: Device: Retisert (fluocinolone acetonide implant)
11 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Interventions: Drug: Dexamethasone;   Drug: dexamethasone;   Drug: Sham injection
12 Recruiting Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
Conditions: Non-infectious Intermediate Uveitis;   Non-infectious Posterior Uveitis;   Non-infectious Panuveitis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
13 Completed Quality of Life in Patients With Intermediate Uveitis
Condition: Macular Edema
Intervention:
14 Active, not recruiting Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Condition: Uveitis, Intermediate
Interventions: Drug: Myfortic;   Drug: Decortin
15 Completed Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Conditions: Uveitis, Intermediate;   Macular Edema;   Multiple Sclerosis
Interventions: Drug: Interferon beta;   Drug: Methotrexate
16 Recruiting Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
Conditions: Uveitis;   Uveitis, Posterior;   Uveitis, Anterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: 4mg CLS-TA Suprachoriodal Injection;   Drug: Sham Procedure
17 Completed Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
18 Not yet recruiting Safety &Efficacy of CF101 to Subjects With Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate
Interventions: Drug: CF101;   Drug: Placebo
19 Terminated Safety and Preliminary Efficacy Study of V404 PDS in Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate
Intervention: Drug: V404
20 Recruiting Study of the Effectiveness of Ozurdex for the Control of Uveitis
Conditions: Uveitis, Intermediate;   Uveitis, Posterior
Intervention: Drug: Dexamethasone pellet

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years